{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-024763","form_type":"8-K","ticker":"DMII","cik":"0002040475","company_name":"Drugs Made In America Acquisition II Corp.","filed_at":"2026-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.099427+00:00","generated_at":"2026-05-15T19:05:32.936818+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Drugs Made In America Acquisition II confirms trust account of ~$507.8M after sponsor irregularities","bullets":["Sponsor made improper withdrawals from working capital between Sep 26, 2025 IPO and Dec 31, 2025.","Board confirmed irregularities did not affect trust account.","As of March 6, 2026, trust account balance is approximately $507,841,957.","The trust account protects public shareholders; no prior disclosure of exact balance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-024763","json":"https://secwatch.observer/filing/0001213900-26-024763.json","markdown":"https://secwatch.observer/filing/0001213900-26-024763.md","text":"https://secwatch.observer/filing/0001213900-26-024763.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026024763/0001213900-26-024763-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026024763/ea028047201-8k_drugs2.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T19:05:32.936818+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}